Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Sequent Scientific posts Rs 30.53 crore profit for Q2

      Sequent Scientific posts Rs 30.53 crore profit for Q2

      Ruby Khatun Khatun13 Nov 2017 9:45 AM IST
      New Delhi: Drug firm Sequent Scientific reported a consolidated net profit of Rs 30.53 crore for the quarter ending September 30.The company had...
      Drugmaker Hikma cuts generics sales forecast a third time

      Drugmaker Hikma cuts generics sales forecast a third time

      Ruby Khatun Khatun13 Nov 2017 9:30 AM IST
      Hikma Pharmaceuticals Plc on Thursday lowered 2017 revenue guidance for its generics business for the third time.The Jordan-based firm, which makes...
      Hester Biosciences Q2 Net up 48 percent at Rs 8.85 crore

      Hester Biosciences Q2 Net up 48 percent at Rs 8.85 crore

      Ruby Khatun Khatun13 Nov 2017 9:10 AM IST
      New Delhi: Animal healthcare firm Hester Biosciences reported a 47.99 percent rise in its standalone net profit to Rs 8.85 crore for the September...
      Sterling Biotech Case : Dont let shark run away for catching small fish, Court tells ED

      Sterling Biotech Case : Don't let shark run away for catching small fish, Court tells ED

      Ruby Khatun Khatun12 Nov 2017 12:30 PM IST
      New Delhi: "Don't let the shark run away while you are busy in catching the small fish," a Delhi court told the Enforcement Directorate.While allowing...
      Novartis India Q2 net up 18 percent at Rs 26 crore

      Novartis India Q2 net up 18 percent at Rs 26 crore

      Ruby Khatun Khatun12 Nov 2017 10:30 AM IST
      New Delhi: Drug firm Novartis India reported a 17.60 percent rise in its net profit to Rs 26.12 crore for the quarter ended September 30, 2017.The...
      UE LifeSciences in distribution partnership with GE Healthcare

      UE LifeSciences in distribution partnership with GE Healthcare

      Ruby Khatun Khatun12 Nov 2017 10:15 AM IST
      Bengaluru: UE LifeSciences Inc, a USA-India based med-tech startup, announced a distribution partnership with GE Healthcare to commercialize its...
      Divis Labs soars 8 percent as USFDA closes out warning letter on Vizag unit

      Divis Labs soars 8 percent as USFDA closes out warning letter on Vizag unit

      Ruby Khatun Khatun12 Nov 2017 10:01 AM IST
      New Delhi: Shares of Divis Laboratories jumped as much as 8 percent to an intraday high of Rs. 1,089.90 against the previous close of Rs. 1,009.75 as...
      Dr Lal Path Labs Q2 net profit dips 4 percent at Rs 50.9 crore

      Dr Lal Path Labs Q2 net profit dips 4 percent at Rs 50.9 crore

      Ruby Khatun Khatun12 Nov 2017 10:00 AM IST
      New Delhi: Diagnostic chain Dr. Lal Path Labs reported a 3.96 percent dip in its consolidated net profit to Rs 50.9 crore for the September quarter of...
      Healthtech startup DocTalk raises Rs 32 crore from Matrix, Khosla Ventures

      Healthtech startup DocTalk raises Rs 32 crore from Matrix, Khosla Ventures

      Ruby Khatun Khatun12 Nov 2017 9:47 AM IST
      DocTalk, a Mumbai based healthcare startup has raised $5 million (Rs 32.43 crore) in its new round of fundingThe funding was raised from Matrix...
      Merck KGaA has contacted prospective buyers of consumer health

      Merck KGaA has contacted prospective buyers of consumer health

      Ruby Khatun Khatun12 Nov 2017 9:45 AM IST
      FRANKFURT: Germany’s Merck KGaA said it has sent information documents on its consumer health business to prospective buyers, kicking off an auction,...
      AstraZeneca rides China wave as rival GlaxoSmithKline struggles

      AstraZeneca rides China wave as rival GlaxoSmithKline struggles

      Ruby Khatun Khatun12 Nov 2017 9:30 AM IST
      LONDON: AstraZeneca is enjoying booming drug sales in China, helped by reforms to the country’s regulatory system and an increased sales force, in...
      Hikma, Vectura in dispute with FDA over generic Advair

      Hikma, Vectura in dispute with FDA over generic Advair

      Ruby Khatun Khatun12 Nov 2017 9:00 AM IST
      LONDON: Hikma and its partner Vectura are in dispute with the Food and Drug Administration over their plans to launch a generic copy of...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok